News

Antion Biosciences, based in Geneva, is at the forefront of cell and gene therapy with its latest breakthrough. They're pioneering the development of next-generation anti-CD19 chimeric antigen receptor

YGION Biomedical GmbH, a company specializing in personalized neoantigen-based cancer vaccines, has successfully completed a Series A financing round, securing €15 million from an Austrian private trust

Imvax, Inc., a biotechnology company specializing in personalized immunotherapies derived from whole tumors, has successfully enrolled participants in its Phase 2b clinical trial for IGV-001, designed for patients

Atara Biotherapeutics, Inc., a leading player in T-cell immunotherapy, has achieved a significant milestone by submitting a Biologics License Application to the U.S. Food and Drug Administration

Rila Therapeutics, a biotech company dedicated to combating chronic fibrotic diseases, has announced the dosing of the first group of subjects in a phase 1 trial of RLA-23174 in China, in collaboration with Yingli Pharmaceutical

Arrowhead Pharmaceuticals, Inc. has announced new interim clinical findings on ARO-RAGE, an RNAi-based therapy designed to treat inflammatory lung conditions such as asthma, during the American Thoracic Society

Drug Farm announced today that the U.S. Food and Drug Administration has given the green light to the Investigational New Drug application for DF-003. This oral alpha-kinase 1

Flamingo Therapeutics has initiated a new Investigator-initiated Trial aimed at assessing the safety and effectiveness of danvatirsen in patients with acute myeloid leukemia and myelodysplastic syndrome

Verrica Pharmaceuticals Inc., specializing in dermatology therapeutics, has announced a significant update to its licensing agreement with Torii Pharmaceutical Co. Ltd. This involves collaborating on a global pivotal Phase 3 clinical trial of YCANTH®

Petros Pharmaceuticals, Inc., a company focused on improving access to medication through over-the-counter drug development programs, has announced that all strengths of its prescription erectile dysfunction medication,